Vanda Pharmaceuticals (VNDA) Stock Chart & Stock Price History $4.99 +0.10 (+2.13%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vanda Pharmaceuticals Stock Price Performance The Vanda Pharmaceuticals (VNDA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 4.69%, with a year-to-date return of 4.26%. In the past month, the stock has increased 13.76%, reflecting recent market activity. As of the latest close, Vanda Pharmaceuticals traded at $4.99 with a market cap of $294.30 million and volume of 293,730 shares. Five years ago, the stock traded at $11.93, representing a 58.14% decrease over that period. At the time, it had a market cap of $624.06 million and a volume of 559,100 shares. Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.81%1 Month Performance+13.76%3 Month Performance+20.63%Year-To-Date Performance+4.26%1 Year Performance-4.69%5 Year Performance-58.14% VNDA Stock Chart for Saturday, July, 5, 2025 VNDA Chart by TradingView Vanda Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$4.99$4.99$5.04$4.86293,730 shs$294.32 million07/03/2025$4.89$4.99+2.13%$5.04$4.86293,730 shs$294.30 million07/02/2025$4.68$4.89+4.49%$4.90$4.70338,619 shs$288.17 million07/01/2025$4.72$4.68-0.85%$4.76$4.66335,590 shs$275.79 million06/30/2025$4.78$4.72-1.26%$4.82$4.71375,218 shs$278.15 million06/27/2025$4.82$4.78-0.83%$4.95$4.75716,308 shs$281.69 million06/26/2025$4.61$4.82+4.56%$4.84$4.54546,711 shs$284.04 million06/25/2025$4.50$4.61+2.44%$4.64$4.38467,290 shs$271.69 million06/24/2025$4.47$4.50+0.67%$4.51$4.45313,202 shs$265.19 million06/23/2025$4.51$4.47-0.89%$4.55$4.40259,658 shs$263.42 million Get the Latest News and Ratings for VNDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$4.53$4.51-0.44%$4.60$4.49323,828 shs$265.79 million06/19/2025$4.53$4.53$4.63$4.50242,234 shs$266.95 million06/18/2025$4.49$4.53+0.89%$4.63$4.50242,234 shs$266.95 million06/17/2025$4.58$4.49-1.97%$4.60$4.48796,913 shs$264.61 million06/16/2025$4.51$4.58+1.55%$4.59$4.48268,499 shs$269.92 million06/13/2025$4.63$4.51-2.59%$4.62$4.51361,867 shs$265.79 million06/12/2025$4.58$4.63+1.09%$4.65$4.52266,972 shs$272.86 million06/11/2025$4.66$4.58-1.72%$4.72$4.58296,187 shs$269.92 million06/10/2025$4.59$4.66+1.53%$4.70$4.49375,208 shs$274.63 million06/09/2025$4.61$4.59-0.43%$4.80$4.56589,751 shs$270.51 million06/06/2025$4.39$4.61+5.01%$4.62$4.41496,480 shs$271.69 million06/05/2025$4.44$4.39-1.13%$4.52$4.37624,851 shs$258.72 million06/04/2025$4.39$4.44+1.14%$4.46$4.38352,515 shs$261.67 million Related Companies Novavax Stock Chart OPKO Health Stock Chart Geron Stock Chart Regulus Therapeutics Stock Chart Myriad Genetics Stock Chart Zenas BioPharma Stock Chart Emergent Biosolutions Stock Chart Rigel Pharmaceuticals Stock Chart XOMA Royalty Stock Chart Lexicon Pharmaceuticals Stock Chart Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VNDA) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
